Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report
Review
OA: closed
CC0
⤵ 18 in-corpus citations
AI-generated summary
This case report describes ovarian endometrioid adenocarcinoma originating in an endometriotic cyst of a postmenopausal woman undergoing tamoxifen treatment for breast cancer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Ovarian cancer arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy is rare.
CASE: We herein report the case of a 67-year-old woman with a history of breast cancer, taking tamoxifen citrate 20 mg/day for 4 years, who underwent an operation for left ovarian tumor. The postoperative histological diagnosis was endometrioid adenocarcinoma in an endometriotic cyst with a gradual transition of the degree of cellular atypia noted from typical endometriotic epithelium, to atypical endometriosis, and finally to adenocarcinoma.
CONCLUSION: Tamoxifen may cause malignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state. Atypical endometriosis may act as a precancerous lesion in the process of tamoxifen-induced malignant transformation of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (19)
- Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy via openalex
- High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen via openalex
- Malignant tumors arising in endometriosis via openalex
- MALIGNANT TUMORS ARISING IN ENDOMETRIOSIS via openalex
- Ovarian atypical endometriosis: its close association with malignant epithelial tumours via openalex
- Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature via openalex
- Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study via openalex
- Ovarian tumors associated with atypical endometriosis via openalex
- Tamoxifen-associated post-menopausal endometriosis via openalex
- W1557623912 via openalex
- W6633274885 via openalex
- W1965740586 via openalex
- W1970928234 via openalex
- W1979285649 via openalex
- W1984435323 via openalex
- W2038922688 via openalex
- W2087081961 via openalex
- W2412806217 via openalex
- W4322701966 via openalex
Cited by (18)
- Endometriosis in Menopausal Women-A New Age Is Coming? Literature Review 2024
- Atypical endometriosis: a review of an incompletely understood putative precursor of endometriosis-associated ovarian carcinoma 2023
- Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature 2021
- Asymptomatic Atypical Hyperplasia and Endometriosis Following Treatment with Tamoxifen: A Case Report and Review of the Literature 2020
- Endometriosis in Menopause-Renewed Attention on a Controversial Disease 2020
- Endométriose 2019
- Postmenopausal endometriosis, where are we now? 2019
- Three cases of clear-cell adenocarcinoma arising from endometrioma during hormonal treatments 2018
- Postmenopausal endometriosis: drawing a clearer clinical picture 2018
- Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary 2015
- Endometriosis after menopause 2015
- Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management 2009
- Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer 2008
- [Postmenopausal malignant transformation of extragenital endometriosis. A case report] 2008
- Endometrioid adenocarcinoma of the ovary arising from endometriosis and presenting as an acute abdomen 2007
- Polypoid endometriosis and other benign gynaecological complications associated with Tamoxifen therapy-a case to illustrate features on magnetic resonance imaging 2006
- Malignant extraovarian endometriosis: a review 2005
- [Endometrioid adenocarcinoma arising from adenomyosis. A case report and literature review] 2004
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:00:45.472718+00:00
- unpaywall
- last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0
· commercial use OK